VBI Vaccines Inc/BC Amortization of Intangible Assets
VBI Vaccines Inc/BC reported Amortization of Intangible Assets of $52.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-13.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2023-03-13
- VBI Vaccines Inc/BC amortization of intangible assets for the quarter ending 2017-12-31 was $17.00K, a 15.00% decline year-over-year.
- VBI Vaccines Inc/BC amortization of intangible assets for the quarter ending 2017-09-30 was $16.00K, a 6.67% increase year-over-year.
- VBI Vaccines Inc/BC amortization of intangible assets for the quarter ending 2017-06-30 was $15.00K, a 6.25% decline year-over-year.
- VBI Vaccines Inc/BC amortization of intangible assets for the quarter ending 2017-03-31 was $15.00K.
- VBI Vaccines Inc/BC amortization of intangible assets for fiscal 2022 was $52.00K, a 22.39% decline from fiscal 2021.
- VBI Vaccines Inc/BC amortization of intangible assets for fiscal 2021 was $67.00K, a 104587.50% increase from fiscal 2020.
- VBI Vaccines Inc/BC amortization of intangible assets for fiscal 2020 was $64.00, a 99.90% decline from fiscal 2019.
- VBI Vaccines Inc/BC amortization of intangible assets for fiscal 2019 was $62.00K, a 1.64% increase from fiscal 2018.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 12 month | Amortization of Intangible Assets 12 month as first filed |
|---|---|---|---|---|---|
| 2022-12-31 | $52.00K 10-K · filed 2023-03-13 | ||||
| 2021-12-31 | $67.00K 10-K · filed 2023-03-13 | $67.00 10-K · filed 2022-03-07 | |||
| 2020-12-31 | $64.00 10-K · filed 2022-03-07 | $64.00K 10-K · filed 2021-03-02 | |||
| 2019-12-31 | $62.00K 10-K · filed 2021-03-02 | ||||
| 2018-12-31 | $61.00K 10-K · filed 2020-03-05 | ||||
| 2017-12-31 | $17.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $33.00K derived: sum of 2 quarters · filed 2018-02-26 | $48.00K derived: sum of 3 quarters · filed 2018-02-26 | $63.00K 10-K · filed 2018-02-26 | |
| 2017-09-30 | $16.00K 10-Q · filed 2017-11-13 | $31.00K derived: sum of 2 quarters · filed 2017-11-13 | $46.00K 10-Q · filed 2017-11-13 | $66.00K derived: sum of 4 quarters · filed 2018-02-26 | |
| 2017-06-30 | $15.00K 10-Q · filed 2017-07-31 | $30.00K 10-Q · filed 2017-07-31 | $50.00K derived: sum of 3 quarters · filed 2018-02-26 | $65.00K derived: sum of 4 quarters · filed 2018-02-26 | |
| 2017-03-31 | $15.00K derived: 10-K 12 month − 3 quarters · filed 2018-02-26 | $35.00K derived: sum of 2 quarters · filed 2018-02-26 | $50.00K derived: sum of 3 quarters · filed 2018-02-26 | $66.00K derived: sum of 4 quarters · filed 2018-02-26 | |
| 2016-12-31 | $20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $35.00K derived: sum of 2 quarters · filed 2018-02-26 | $51.00K derived: sum of 3 quarters · filed 2018-02-26 | $66.00K 10-K · filed 2018-02-26 | |
| 2016-09-30 | $15.00K 10-Q · filed 2017-11-13 | $31.00K derived: sum of 2 quarters · filed 2017-11-13 | $46.00K 10-Q · filed 2017-11-13 | ||
| 2016-06-30 | $16.00K 10-Q · filed 2017-07-31 | $31.00K 10-Q · filed 2017-07-31 | |||
| 2015-12-31 | $64.00K 10-K · filed 2018-02-26 |